Evidence map›Paper›PMID 32195222›Full record

ArticleFrontiers in chemistry2020

Construction of 1D Ag-AgBr/AlOOH Plasmonic Photocatalyst for Degradation of Tetracycline Hydrochloride.

Siyang Zhang, Iltaf Khan, Xiaohong Qin, Kezhen Qi, Ying Liu, Shuchong Bai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. 3D/3D Bamboo Charcoal/BiMolecules (Basel, Switzerland) · 2024
    Article
  3. Review
  4. Review
  5. 2D/2D Biochar/BiACS omega · 2023
    Article
  6. Review
  7. Review
  8. Graphitic carbon nitride (g-CFrontiers in chemistry · 2022
    Review
  9. Article
  10. Photocatalytic Removal of Antibiotics on g-CFrontiers in chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Siyang ZhangInstitute of Catalysis for Energy and Environment, College of Chemistry and Chemical Engineering, Shenyang Normal University, Shenyang, China.
Iltaf KhanKey Laboratory of Functional Inorganic Materials Chemistry, School of Chemistry and Materials Science, Heilongjiang University, Harbin, China.
Xiaohong QinDepartment of Information and Control Engineering, Shenyang Institute of Science and Technology, Shenyang, China.
Kezhen QiInstitute of Catalysis for Energy and Environment, College of Chemistry and Chemical Engineering, Shenyang Normal University, Shenyang, China.
Ying LiuInstitute of Catalysis for Energy and Environment, College of Chemistry and Chemical Engineering, Shenyang Normal University, Shenyang, China.
Shuchong BaiInstitute of Paleontological, Shenyang Normal University, Shenyang, China.
Shenyang Normal University · CNHeilongjiang University · CNShenyang Institute of Engineering · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, the highly efficient and low-cost Ag-AgBr/AlOOH plasmonic photocatalyst is successfully prepared via a simple and mild wet-chemical process and used for degrading high concentration methylene blue (MB) and tetracycline hydrochloride (TCH). The optimized 6-Ag-AgBr/AlOOH sample showed a 79% decomposition of TCH in 2 h, which is almost two times higher than that of bare AgBr (37%). For degrading MB, the photocatalytic activity of 6-Ag-AgBr/AlOOH (decomposing 84% in 2 h) showed a large enhancement as compared to bare AgBr (only 57%). The TEM, HRTEM, XRD, DRS, and XPS characterization results confirm that Ag-AgBr is a composite catalyst formed by loading Ag nanoparticles onto AgBr surfaces and then loaded on to AlOOH. The possible mechanism proposed is that •

Indexed as

Ag-AgBr/AlOOHdegradationmethylene blueplasmonic photocatalysttetracycline hydrochloride

Identifiers

PMID32195222
PMCPMC7066255
OpenAlexW3010031682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.